MARKET

INO

INO

Inovio Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.450
-0.070
-2.78%
After Hours: 2.450 0 0.00% 16:00 11/11 EST
OPEN
2.480
PREV CLOSE
2.520
HIGH
2.500
LOW
2.410
VOLUME
808.73K
TURNOVER
--
52 WEEK HIGH
5.47
52 WEEK LOW
1.915
MARKET CAP
242.62M
P/E (TTM)
-2.0200
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INO News

  • Inovio up 20% on positive INO-5401 data
  • seekingalpha.6d ago
  • Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
  • Zacks.6d ago
  • ADBE, NIO among premarket gainers
  • Seeking Alpha - Article.6d ago
  • Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)
  • PR Newswire.6d ago

More

Industry

Biotechnology & Medical Research
-0.40%
Pharmaceuticals & Medical Research
-0.41%

Hot Stocks

Name
Price
%Change

About INO

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.
More

Webull offers Inovio Pharmaceuticals Inc (INO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.